Syneron Medical Ltd. (NASDAQ:ELOS)

CAPS Rating: 4 out of 5

The Company designs, develops and markets innovative aesthetic medical products based on its ELOS, technology, which uses the synergy between electrical energy and optical energy to provide effective, safe and affordable aesthetic medical treatments.

Results 1 - 20 of 99 : 1 2 3 4 5 Next »

Recs

0
Member Avatar TMFSpiffyPop (99.23) Submitted: 12/15/2011 9:24:27 AM : Outperform Start Price: $10.16 ELOS Score: -48.83

This former Rule Breaker has bounced back pretty well from our sell recommendation in 2009. It has a lot of cash (always did), so the underlying business isn't priced for much. I'll rejoin the fray on this one and give it another green thumb. Please note, this may be a contrary indicator: I struck out in my first at-bat with ELOS.

Recs

0
Member Avatar Laice1 (20.97) Submitted: 5/2/2011 3:44:04 PM : Outperform Start Price: $12.13 ELOS Score: -49.76

Just hit the 100 mva on the daily 1 year chart. May close the gap at the 11.70 area. Expect buyers around this. Undervalued, with some brokers targeting $17.25

Recs

0
Member Avatar GreatStocks3728 (< 20) Submitted: 4/16/2010 8:28:45 AM : Outperform Start Price: $11.05 ELOS Score: -58.13

Good earnings.

Recs

1
Member Avatar foolstracker (< 20) Submitted: 4/11/2010 5:36:32 PM : Outperform Start Price: $10.80 ELOS Score: -57.64

stock of the day

Recs

0
Member Avatar chrisp9 (52.17) Submitted: 2/22/2010 8:26:21 PM : Underperform Start Price: $9.42 ELOS Score: +56.86

It's profits are shrinking that's just not a good sign long term.

Recs

0
Member Avatar jerseytix (32.83) Submitted: 5/8/2009 6:04:07 AM : Underperform Start Price: $7.38 ELOS Score: +63.75

Stock is trading just above cash but there is significant macro pressure on elective surgery, plus competition from Cutera, Cynosure and Candela. There's a reason all 4 stocks are trading at enterprise value, because all 4 aren't going to make it through this recession.

Recs

1
Member Avatar lllchicalll (79.13) Submitted: 2/15/2009 5:35:04 PM : Outperform Start Price: $5.86 ELOS Score: -61.59

bravobevo

Recs

0
Member Avatar RockyNicky3728S (42.80) Submitted: 12/25/2008 3:41:52 PM : Outperform Start Price: $7.86 ELOS Score: -82.27

Great growth and future earnings.

Recs

0
Member Avatar ValueMrk (99.44) Submitted: 11/24/2008 9:06:28 AM : Outperform Start Price: $6.49 ELOS Score: -72.60

Medical technology good long-term value.

Recs

0
Member Avatar WhyBeI (74.76) Submitted: 11/14/2008 4:36:56 PM : Outperform Start Price: $7.75 ELOS Score: -84.46

Sells at cash value. Are you kidding?

Recs

2
Member Avatar tenmiles (99.92) Submitted: 10/20/2008 1:16:09 PM : Outperform Start Price: $9.87 ELOS Score: -88.09

Deep value play for a number of prominent investors has become an even deeper value after recent earnings miss. Sub $10 looks like good entry point - technicals suggest we are nearing short-term bottom, while value metrics seem compelling - debt free, 60% of market cap in cash, small premium to book. Likely dead money for a while, but solid 3-5 year recovery prospects from current level.

Recs

0
Member Avatar EagleTraderOne (< 20) Submitted: 9/10/2008 4:54:35 PM : Underperform Start Price: $14.60 ELOS Score: +80.16

Still a way to go...down. Not a buy...yet.

Recs

0
Member Avatar kaz324 (< 20) Submitted: 8/30/2008 4:11:41 PM : Outperform Start Price: $16.65 ELOS Score: -78.90

Technical bottom, Fantastic balance sheet, net income to sales ratio is high (20 to 50%), no capital needed to grow, tiny depreciation charge, some great and famous individual investors are accumulating it. What I call a growth company at a value price.

Recs

2
Member Avatar chaga269 (93.16) Submitted: 8/7/2008 4:39:24 PM : Underperform Start Price: $14.32 ELOS Score: +74.08

People might not be too excited about spending more money on their products, while the credit card debt, mortgage, prices in general are all increasing. Also, more people are losing their jobs. Might be best to stay away from these stocks for now.

Recs

0
Member Avatar outoffocus (24.51) Submitted: 7/13/2008 10:58:44 PM : Outperform Start Price: $14.93 ELOS Score: -77.83

This company has solid fundamentals. Low Price to book ratio. Low debt to equity and solid earnings. In this bear market you need whatever good companies you can find.

Recs

1
Member Avatar gilliam1983 (< 20) Submitted: 7/3/2008 2:59:20 AM : Outperform Start Price: $14.93 ELOS Score: -75.99

You gotta love a BEAR market. There are so many great stocks trading at levels I usually only dream about. Not much of a downside here. Expect a minimum of a 50% return, but closer to 75-100%. Dont b fooled fools, this is know value trap. 0 debt and mgmt buying back shares.

Recs

1
Member Avatar jonlanglois (75.40) Submitted: 6/17/2008 11:46:01 AM : Outperform Start Price: $17.56 ELOS Score: -76.50

I've held this stock since before the October plunge...I do think it was overdone. The company still seems well-managed. The larger trend of an aging population bodes well for its product line, though the near-term economic uncertainty might make customers a bit hesitant.

Recs

1
Member Avatar stohks (< 20) Submitted: 5/26/2008 6:35:28 PM : Outperform Start Price: $16.37 ELOS Score: -71.32

because I am putting my money where my mouth is.

Recs

1
Member Avatar SportAg22 (< 20) Submitted: 4/29/2008 12:45:35 AM : Outperform Start Price: $15.10 ELOS Score: -65.49

Important to note that insurances are covering/reimbursing certain procedures!

Recs

0
Member Avatar TripleTTT (< 20) Submitted: 3/26/2008 4:59:37 PM : Outperform Start Price: $14.83 ELOS Score: -69.14

Safety & hi growth potential

Results 1 - 20 of 99 : 1 2 3 4 5 Next »

Featured Broker Partners


Advertisement